Prognostic significance of cyclin E overexpression in resected non-small cell lung cancer

Cancer Research

Volumn 60, Issue 2, 2000, Pages 242-244

  Fukuse, Tatsuo ^a   Hirata, Toshiki ^a   Naiki, Hironobu ^b   Hitomi, Shigeki ^a   Wada, Hiromi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; CYCLIN E;

ADULT; ARTICLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; FEMALE; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CYCLIN E; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0034650259     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Pines, J., and Hunter, T. Isolation of a human cyclin cDNA: evidence for cyclin in RNA and protein regulation in the cell cycle for interaction with p34cdc2. Cell, 58: 833-846, 1989.
2. 1 phase of the human cell cycle. Science (Washington DC), 257: 1689-1694, 1992.
3. 1 cyclins. Cell, 73: 1059-1065, 1993.
4. Keyomarsi, K., O'Leary, N., Molnar, G., Lees, E., Fingert, H.J., and Pardee, A. B. Cyclin E, a potential prognostic marker for breast cancer. Cancer Res., 54: 380-385, 1994.
5. Dutta, A., Chandra, R., Leiter, L. M, and Lester, S. Cyclins as markers of tumor proliferation: immunohistochemical studies in breast cancer. Proc. Natl. Acad. Sci. USA, 92: 5386-5390, 1995.
6. Nielsen, N. H., Arnerlöv, C., Emdin, S. O., and Landberg, G. Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status. Br. J. Cancer. 74: 874-880, 1996.
7. Betticher, D. C., Heighway, J., Hasleton, P. S., Altermatt, H. J., Ryder, W. D. J., Cerny, T., and Thatcher, N. Prognostic significance of CCND (cyclin DI) overexpression in primary resected non-small-cell lung cancer. Br. J. Cancer, 73: 294-300, 1996.
8. McIntosh, G. G., Anderson, J. J., Milton, I., Steward, M., Parr, A. H., Thomas, M. D., Henry, J. A., Angus, B., Lennard, T. W., and, Horne, C. H. Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene, 11: 885-891, 1995.
9. Pujol, J. L., Simony, J., and Jolimoy, G. Hypodiploidy. Ki-67 growth fraction and prognosis of surgically resected lung cancers. Br. J. Cancer, 74: 964-970, 1996.
10. Bravo, R., Frank, R., Blundell, P. A., and MacDonald-Bravo, H. Cyclin/PCNA is the auxiliary protein of DNA polymerase delta. Nature (Lond.), 326: 515-517, 1987.
11. Mathews, M. B., Bernstein, R. M., Franza, B. R., and Garrels, J. I. Identity of the proliferating cell nuclear antigen and cyclin. Nature (Lond.), 309: 374-376, 1984.
12. Fukuse, T., Hirata, T., Naiki, H., Hitomi, S., and Wada, H. Expression of proliferating cell nuclear antigen and CD44 variant isoforms in primary and metastatic sites of non-small cell lung cancer with intrapulmonary metastases. Cancer (Phila.), 86: 1174-1181, 1999.
13. Fontanini, G., Macchiarini, P., Pepe, S., Ruggiero, A., Hardin, M., Bigini, D., Vignati, S., Pingitore, R., and Angeletti, C. A. The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node-negative non-small cell lung cancer. Cancer (Phila.), 70: 1520-1527, 1992.
14. International Union Against Cancer. TNM Classification of Malignant Tumours, pp. 93-97, Ed. 5. New York: Wiley-Liss, 1997.
15. Hirata, T., Fukuse, T., Naiki, H., Hitomi, S., and Wada, H. Expression of CD44 variant exon 6 in Stage 1 non-small cell lung carcinoma as a prognostic factor. Cancer Res., 58: 1108-1110, 1998.
16. Sakaguchi, T., Watanabe, A., and Sawada, H. Prognostic value of cyclin E and p53 expression in gastric carcinoma. Cancer (Phila.), 82: 1238-1243, 1998.
17. Wang, A., Yoshimi, N., Suzui, M., Yamauchi, A., Tarao, M., and Mori, H. Different expression patterns of cyclins A, D1, and E in human colorectal cancer. J. Cancer Res. Clin. Oncol., 122: 122-126, 1996.
18. Porter, P. L., Malone, K. E., Heagerty, P. J., Alexander, G. M., Gatti, L. A., Firpo, E. J., Daling, J. R., and Roberts, J. M. Expression of cell-cycle regulators p27kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat. Med., 3: 221-225, 1997.
19. Bergers, G., Javaherian, K., Lo, K. M., Folkman, J., and Hanahan, D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science (Washington DC), 284: 808-812, 1999.